Cosmos Health Inc. COSM revenue by segment, product and geography
In its fiscal year ending 2025-12-31, Cosmos Health Inc. reported revenue across 4 business segments; the largest, Wholesale, was $59.3M, 90.9% of the filed sum (+15.0% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Wholesale$59.3M90.9%+15.0% yoy
- Nutraceuticals And Pharmaceuticals$4.26M6.5%+116.7% yoy
- Pharmamanufacturing$1.69M2.6%+95.2% yoy
- Other$1.23K0.0%no prior
Members sum to the consolidated $65.3M for this period.
- Wholesale$16.9M94.2%+35.1% yoy
- Nutraceuticals And Pharmaceuticals$796K4.4%-15.2% yoy
- Pharmamanufacturing$238K1.3%-11.3% yoy
- Other$4850.0%no prior
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.